AI assistant
Sending…
Solid Biosciences Inc. — Director's Dealing 2021
Feb 1, 2021
33003_dirs_2021-02-01_c535d63f-15e2-4ef1-9cf9-09297ffa3e7f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2021-01-29
Reporting Person: DiPalma Stephen J. (Interim CFO)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Warrant (right to buy) | $3.29 | 2030-11-19 | Common Stock (30000) | Indirect |
Footnotes
F1: The warrant was issued on November 20, 2020 and vests on a monthly basis over six months from the date of issuance.
F2: The warrant was issued to Danforth Advisors, LLC, of which the Reporting Person is a Managing Director, pursuant to a consulting agreement, dated November 19, 2020, between the Issuer and Danforth Advisors, LLC.
More from Solid Biosciences Inc.
Interim / Quarterly Report
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 23
Board/Management Information
2026
Apr 10
Capital/Financing Update
2026
Mar 19
Annual Report
2026
Mar 19
Major Shareholding Notification
2026
Mar 17
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19